Novonesis A/S (OTC:NVZMY) Stock Price Up 1.8% - Should You Buy?

Novonesis A/S (OTC:NVZMY - Get Free Report)'s share price traded up 1.8% during mid-day trading on Friday . The stock traded as high as $74.20 and last traded at $72.98. 46,047 shares changed hands during mid-day trading, an increase of 33% from the average session volume of 34,722 shares. The stock had previously closed at $71.67.

Novonesis A/S Trading Up 1.8%

The company has a market cap of $34.18 billion, a P/E ratio of 46.19, a PEG ratio of 2.79 and a beta of 0.92. The business's 50 day simple moving average is $65.13 and its 200 day simple moving average is $60.25.

Novonesis A/S Company Profile

Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.